New ablation treatment for irregular heartbeat
Part of Heart & circulation clinical trials.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptomatic atrial fibrillation (irregular heartbeat with noticeable symptoms) that didn't improve with medication
- Your heart's left upper chamber is not too enlarged (less than 5.5 cm across) and doesn't have too much fluid in it
- You've never had surgery or ablation (heat/cold treatment) on your heart for rhythm problems before
- You don't have certain heart devices like pacemakers, implantable defibrillators, or devices to close heart holes
- Your heart pumps well enough (ejection fraction at least 40%) and you're not in advanced heart failure
- You're willing to take blood thinners around the procedure and return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a new system that maps and treats atrial fibrillation using special energy (pulsed field ablation) during a repeat ablation procedure. It also uses a small implanted monitor to track your heart rhythm before and after the procedure, which may help improve outcomes.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests two types of pulsed field ablation catheters to treat persistent atrial fibrillation, a heart rhythm problem lasting more than 7 days but less than a year. The goal is to see if these catheters can safely and effectively restore a normal heart rhythm.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.